There are hundreds of drugmakers and diagnostics companies making noise about their coronavirus projects, and it isn't always easy to separate signals worth listening to from all the noise. If you want to focus on the pharma industry's members most likely to impact the spread of 2019-nCoV infection, though, here are three good places to start.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,